Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

593 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

NCT05315700

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Huntington Beach, California, United States
  • City of Hope Irvine, California, United States
  • City of Hope Long Beach, California, United States
View all 42 locations
View Trial Details
Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

NCT06644755

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liposarcoma, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • UZ Leuven Europe Leuven Leuven, Belgium
View Trial Details
Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • Arizona Cancer Center at UMC North ( Site 0018) Tucson, Arizona, United States
  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0016) Fresno, California, United States
  • Providence Medical Foundation ( Site 0087) Fullerton, California, United States
View all 782 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • New York Medical College Valhalla, New York, United States
  • Carolinas Medical Center/ Levine Children's Hospital Charlotte, North Carolina, United States
  • Levine Children's Health Charlotte, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

NCT05536141

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site San Diego, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

NCT07492680

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +22 more
Locations
  • Local Institution - 0096 San Francisco, California, United States
  • Local Institution - 0182 Aurora, Colorado, United States
  • Local Institution - 0178 Atlanta, Georgia, United States
  • Local Institution - 0124 Boston, Massachusetts, United States
View all 57 locations
View Trial Details
Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

NCT06885281

Conditions
Solid Tumors
Locations
  • University of California San Francisco/Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • OSF St. Francis Medical Center Peoria, Illinois, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 23 locations
View Trial Details

Related conditions